Seismic Therapeutic
Elliott Wittenberg has had a varied work experience since 2011. Elliott began as a Dock Hand at Clipper Navigation in 2013 and then moved on to become Chief of Staff at Lincoln Square Cinemas in 2011. In 2014, they were a Research and Development Intern at Saint-Gobain Abrasives, followed by an AD/QC Intern at Acorda Therapeutics, Inc. in 2015. In 2016, they became a Co-op, Protein Sciences at Jounce Therapeutics, Inc. and then a Contracted Associate Scientist with Pfizer Inc. in 2017. In 2018, they were a Research Associate at Tilos Therapeutics, followed by a Research Associate at Arbor Biotechnologies in 2019. In 2020, they became a Senior Research Associate and Research Associate II at Revitope, and they are currently a Senior Associate Scientist I at Seismic Therapeutics.
Elliott Wittenberg obtained a Bachelor of Science (B.S.) in Chemical Engineering from Northeastern University between 2012 and 2017. Elliott also attended Swinburne University of Technology in 2012, but did not obtain a degree.
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.